IF YOU PRESCRIBE SUBSCRIBE

If you’re a health professional, subscribe to receive regular email updates from Australian Prescriber

Subscribe
Experimental and Clinical Pharmacology Andrew Somogyi, Felix Bochner, David Foster
  • 1 April 2004
Letters to the Editor

New drug comment - escitalopram

  • 1 April 2004
Letters to the Editor

Drug-induced hyponatraemia

J. R. Stockigt, Robin Hunter, Spiros Fourlanos, Peter Greenberg
  • 1 April 2004
Letters to the Editor

Traditional Chinese medicines

Malcolm Parker, George Q. Li, Colin C. Duke, Basil D. Roufogalis
  • 1 April 2004
Experimental and Clinical Pharmacology

Tumour necrosis factor alpha inhibitors for the treatment of adult rheumatoid arthritis

Geoff McColl
  • 1 April 2004
Letters to the Editor

Bisphosphonates and avascular necrosis of the jaws

G. D. Carter, A. N. Goss
  • 1 April 2004
Letters to the Editor

New drug comment - pimecrolimus

  • 1 April 2004
Letters to the Editor

Promotion of over-the-counter medicines

  • 1 April 2004
Letters to the Editor

Oximetry

  • 1 April 2004
Article

Diabetes and periodontitis

Robert Hirsch
  • 1 April 2004
Letters to the Editor

Withdrawal of useful drugs

  • 1 April 2004
Book review

Therapeutic Guidelines: Psychotropic. Version 5.

Ian Wilson
  • 1 April 2004
Editorial

Trouble with tramadol

Karen Kaye
  • 1 April 2004
Letters to the Editor

Paediatric formulations

  • 1 April 2004
Letters to the Editor

BCG vaccination in Australia

  • 1 April 2004
NEW DRUGS
Insulin glargine
  • 1 March 2004
Perindopril erbumine
  • 1 March 2004
Influenza vaccine
  • 1 March 2004
Azithromycin
  • 1 March 2004
Methylphenidate
  • 1 March 2004
Lercanidipine
  • 1 March 2004
Leuprorelin acetate
  • 1 March 2004

IF YOU PRESCRIBE SUBSCRIBE

If you’re a health professional, subscribe to receive regular email updates from Australian Prescriber

Subscribe